The Beezaasan Explotech IPO is a closed SME Bookbuilding offer (Fresh Capital) that opened on 21 February 2025. The Beezaasan Explotech IPO closed on 25 February 2025, with an issue price of ₹175 per share. The Beezaasan Explotech IPO has a face value of ₹10 and a lot size of 800 shares. The Beezaasan Explotech IPO is listed on 3 March 2025. The Beezaasan Explotech IPO allotment was scheduled for 27 February 2025.
On the financial front, the Beezaasan Explotech IPO reported revenue of ₹101 crore for 30 Sep 2024, compared with ₹188 crore for 31 Mar 2024. The Beezaasan Explotech IPO PAT was ₹8 crore against ₹5 crore. The Beezaasan Explotech IPO net worth as of 30 Sep 2024 was ₹31 crore.
Always verify The Beezaasan Explotech IPO details and GMP data with the official offer document before investing in the Beezaasan Explotech IPO.
Financial Summary
Amount in ₹ Crore
Metric
30 Sep 2024
31 Mar 2024
31 Mar 2023
Total Assets
82
69
62
Revenue
101
188
229
PAT
8
5
3
Net Worth
31
23
14
Reserves
22
14
7
Total Borrowing
40
37
43
Beezaasan Explotech IPO Financials FAQs
Revenue of Beezaasan Explotech (Amount in ₹ Crore) — 30 Sep 2024: 101; 31 Mar 2024: 188; 31 Mar 2023: 229. Profit after tax (PAT) — 30 Sep 2024: 8; 31 Mar 2024: 5; 31 Mar 2023: 3.
Total assets — 30 Sep 2024: 82; 31 Mar 2024: 69; 31 Mar 2023: 62. Net worth — 30 Sep 2024: 31; 31 Mar 2024: 23; 31 Mar 2023: 14. Reserves & surplus — 30 Sep 2024: 22; 31 Mar 2024: 14; 31 Mar 2023: 7. (Amount in ₹ Crore)
Total borrowing of Beezaasan Explotech (Amount in ₹ Crore) — 30 Sep 2024: 40; 31 Mar 2024: 37; 31 Mar 2023: 43. Debt-to-equity ratio: 1.59.
The financials shown for Beezaasan Explotech IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
